High optode-density wearable diffuse optical probe for monitoring paced breathing hemodynamics in breast tissue.


Journal

Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853

Informations de publication

Date de publication:
06 2021
Historique:
received: 16 10 2020
accepted: 16 05 2021
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 25 9 2021
Statut: ppublish

Résumé

Diffuse optical imaging (DOI) provides in vivo quantification of tissue chromophores such as oxy- and deoxyhemoglobin (HbO2 and HHb, respectively). These parameters have been shown to be useful for predicting neoadjuvant treatment response in breast cancer patients. However, most DOI devices designed for the breast are nonportable, making frequent longitudinal monitoring during treatment a challenge. Furthermore, hemodynamics related to the respiratory cycle are currently unexplored in the breast and may have prognostic value. To design, fabricate, and validate a high optode-density wearable continuous wave diffuse optical probe for the monitoring of breathing hemodynamics in breast tissue. The probe has a rigid-flex design with 16 dual-wavelength sources and 16 detectors. Performance was characterized on tissue-simulating phantoms, and validation was performed through flow phantom and cuff occlusion measurements. The breasts of N  =  4 healthy volunteers were measured while performing a breathing protocol. The probe has 512 unique source-detector (S-D) pairs that span S-D separations of 10 to 54 mm. It exhibited good performance characteristics: μa drift of 0.34%/h, μa precision of 0.063%, and mean SNR  ≥  24  dB up to 41 mm S-D separation. Absorption contrast was detected in flow phantoms at depths exceeding 28 mm. A cuff occlusion measurement confirmed the ability of the probe to track expected hemodynamics in vivo. Breast measurements on healthy volunteers during paced breathing revealed median signal-to-motion artifact ratios ranging from 8.1 to 8.7 dB. Median ΔHbO2 and ΔHHb amplitudes ranged from 0.39 to 0.67  μM and 0.08 to 0.12  μM, respectively. Median oxygen saturations at the respiratory rate ranged from 82% to 87%. A wearable diffuse optical probe has been designed and fabricated for the measurement of breast tissue hemodynamics. This device is capable of quantifying breathing-related hemodynamics in healthy breast tissue.

Identifiants

pubmed: 34080400
pii: JBO-200339SSR
doi: 10.1117/1.JBO.26.6.062708
pmc: PMC8170390
doi:

Substances chimiques

Oxyhemoglobins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIBIB NIH HHS
ID : U54 EB015403
Pays : United States

Références

Clin Cancer Res. 2020 Jun 15;26(12):2771-2773
pubmed: 32265219
Neuroimage. 2004;23 Suppl 1:S275-88
pubmed: 15501097
Appl Opt. 1997 Jan 1;36(1):386-96
pubmed: 18250686
J Biomed Opt. 2016 Oct;21(10):101408
pubmed: 26926870
J Biomed Opt. 2000 Apr;5(2):206-13
pubmed: 10938785
Opt Lett. 2003 Dec 1;28(23):2339-41
pubmed: 14680175
Cancer. 2005 Sep 15;104(6):1149-57
pubmed: 16088887
Radiology. 2018 Jun;287(3):778-786
pubmed: 29431574
Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4512-30
pubmed: 22006904
J Biomed Opt. 2021 Mar;26(3):
pubmed: 33768742
Biomed Opt Express. 2017 Jan 04;8(2):555-569
pubmed: 28270967
J Biomed Opt. 2012 Jul;17(7):071311
pubmed: 22894472
Crit Care Med. 1997 Sep;25(9):1579-82
pubmed: 9295835
J Biomed Opt. 2016 Sep;21(9):091314
pubmed: 27467190
J Biomed Opt. 2017 Mar 1;22(3):36009
pubmed: 28280840
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4014-9
pubmed: 17360469
Philos Trans R Soc Lond B Biol Sci. 1997 Jun 29;352(1354):707-16
pubmed: 9232859
Neurophotonics. 2016 Oct;3(4):045002
pubmed: 27752518
Acad Radiol. 2014 Feb;21(2):162-7
pubmed: 24439329
J Biomed Opt. 2017 Aug;22(12):1-9
pubmed: 28831792
J Biomed Opt. 2004 May-Jun;9(3):534-40
pubmed: 15189091
J Appl Physiol (1985). 2002 Jan;92(1):372-84
pubmed: 11744680
Biomed Opt Express. 2012 May 1;3(5):878-98
pubmed: 22567582
Phys Med Biol. 1992 Jul;37(7):1531-60
pubmed: 1631197
Ann Surg Oncol. 2018 Aug;25(8):2241-2248
pubmed: 29786125
J Biomed Opt. 2017 Dec;22(12):1-9
pubmed: 29264893
Phys Med Biol. 2002 Aug 21;47(16):2847-61
pubmed: 12222850
Opt Express. 2008 Jul 7;16(14):10323-30
pubmed: 18607442
J Biomed Opt. 2017 Jan 1;22(1):14001
pubmed: 28114449
J Biomed Opt. 2018 Apr;23(4):1-5
pubmed: 29706036
Rev Sci Instrum. 2009 Apr;80(4):043704
pubmed: 19405663
Cancer Res. 2016 Oct 15;76(20):5933-5944
pubmed: 27527559
Commun Numer Methods Eng. 2008 Aug 15;25(6):711-732
pubmed: 20182646
J Nucl Med. 2016 Aug;57(8):1189-95
pubmed: 26940765
Phys Med Biol. 2012 May 21;57(10):2857-72
pubmed: 22513789
Nat Photonics. 2014 Jun;8(6):448-454
pubmed: 25083161
Transl Oncol. 2012 Aug;5(4):238-46
pubmed: 22937175
Clin Cancer Res. 2010 May 1;16(9):2605-14
pubmed: 20406836
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14626-31
pubmed: 21852577
J Biomed Opt. 2011 Jul;16(7):076014
pubmed: 21806275
J Biomed Opt. 2018 Jan;23(1):1-14
pubmed: 29368457
Phys Med Biol. 2006 Mar 7;51(5):N91-8
pubmed: 16481677
Ultrason Imaging. 1998 Oct;20(4):260-74
pubmed: 10197347
J Vasc Surg. 2020 Mar;71(3):946-957
pubmed: 31445826
J Biomed Opt. 2013 Sep;18(9):096012
pubmed: 24048367
J Biomed Opt. 2009 Mar-Apr;14(2):024012
pubmed: 19405742
Phys Med Biol. 2007 Mar 21;52(6):1565-76
pubmed: 17327649

Auteurs

Samuel Spink (S)

Boston Univ., United States.

Fei Teng (F)

Boston Univ., United States.

Vivian Pera (V)

Boston Univ., United States.

Hannah Peterson (H)

Boston Univ., United States.

Tim Cormier (T)

Boston Univ., United States.
Fraunhofer USA Ctr. for Manufacturing Innovation CMI, United States.

Alexis Sauer-Budge (A)

Boston Univ., United States.
Fraunhofer USA Ctr. for Manufacturing Innovation CMI, United States.

David Chargin (D)

Boston Univ., United States.
Fraunhofer USA Ctr. for Manufacturing Innovation CMI, United States.

Sam Brookfield (S)

Boston Univ., United States.
Fraunhofer USA Ctr. for Manufacturing Innovation CMI, United States.

Adam Eggebrecht (A)

Washington Univ. School of Medicine in St. Louis, United States.

Naomi Yu Ko (NY)

Boston Medical Ctr., United States.

Darren Roblyer (D)

Boston Univ., United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH